SAN FRANCISCO — The JPMorgan Healthcare Conference continued to yield mixed results for investors in its second day Tuesday, as several companies tweaked their guidance and big pharmas offered incremental updates. Specialty drugmaker Horizon Pharma (HZNP) had the best day, as its shares rose 6.2%, to 19.21, after the company updated its guidance ahead of its presentation Wednesday. Horizon said in a press release that its buyout of
After six months or so of talks, Big Pharmas Shire and Baxalta early Monday announced a merger, valued near $32 billion, that they said would create the No. 1 company in drugs to treat rare diseases. Ireland-based Shire (SHPG) will pay Baxalta (BXLT) shareholders $18 in cash and 0.1482 of a Shire ADS (American Depositary Share) per share owned. They said that comes to $45.57 per Baxalta share, based on Friday’s closing price. But
Cyber cash registers continued to ring late this week, as shoppers seemed to wait later this season than in past years to wrap up holiday shopping. The so-called Amazon.com (AMZN) effect — its Prime loyalty program includes free two-day shipping and relatively low-cost one-day or same-day shipping, which shoppers have come to expect in general — contributed to a U-shaped pattern of holiday buying, with heavy spending early and